Disruptive chemicals, senescence and immortality.
暂无分享,去创建一个
William H. Bisson | A. Colacci | E. Ryan | L. Memeo | J. Wise | F. Al-Mulla | A. Carnero | Jayadev Raju | C. Blanco-Aparicio | A. Scovassi | M. Vaccari | A. Amedei | C. Mondello | Dustin G. Brown | H. Kondoh | H. Salem | Jordan Woodrick | M. Lleonart | Neetu Singh | R. Al-Temaimi | R. Roy | R. A. Hamid | S. Wise | S. Forte | W. Bisson | Hemad Yasaei | Juan F Martínez-Leal
[1] Wenwei Hu,et al. Tumor suppressor p53 and its mutants in cancer metabolism. , 2015, Cancer letters.
[2] James H Doroshow,et al. Molecular mechanisms underlying chronic inflammation-associated cancers. , 2014, Cancer letters.
[3] K. O'Byrne,et al. Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC. , 2014, Cancer treatment reviews.
[4] Jinhua Wang,et al. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1. , 2014, Neuro-oncology.
[5] M. Korc,et al. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. , 2014, The Journal of clinical investigation.
[6] J. Sharpe,et al. Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning , 2013, Cell.
[7] A. Rodríguez-Baeza,et al. Programmed Cell Senescence during Mammalian Embryonic Development , 2013, Cell.
[8] P. Codogno,et al. Autophagy regulation and its role in cancer. , 2013, Seminars in cancer biology.
[9] B. Zingarelli,et al. mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells , 2013, Leukemia.
[10] V. Tergaonkar,et al. Telomerase: central regulator of all of the hallmarks of cancer. , 2013, Trends in biochemical sciences.
[11] E. Cuyás,et al. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway , 2013, Cell cycle.
[12] Soyoung Lee,et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy , 2013, Nature.
[13] Pauline M. Wu,et al. ATF4 activation by the p38MAPK–eIF4E axis mediates apoptosis and autophagy induced by selenite in Jurkat cells , 2013, FEBS letters.
[14] Z. Li,et al. Sodium selenite induces apoptosis in colon cancer cells via Bax-dependent mitochondrial pathway. , 2013, European review for medical and pharmacological sciences.
[15] F. Rösl,et al. Post-Translational Control of IL-1β via the Human Papillomavirus Type 16 E6 Oncoprotein: A Novel Mechanism of Innate Immune Escape Mediated by the E3-Ubiquitin Ligase E6-AP and p53 , 2013, PLoS pathogens.
[16] Giovanni Tesoriere,et al. RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis , 2013, Journal of cellular physiology.
[17] Shuang-yin Han,et al. Anti-apoptotic proteins and catalase-dependent apoptosis resistance in nickel chloride-transformed human lung epithelial cells , 2013, International journal of oncology.
[18] Kelly J. Morris,et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence , 2013, Nature Cell Biology.
[19] T. Shlomi,et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence , 2013, Nature.
[20] P. Fraisl. Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis. , 2013, Experimental cell research.
[21] E. Macit,et al. The Effects of N-Acetylcysteine and Ozone Therapy on Oxidative Stress and Inflammation in Acetaminophen-Induced Nephrotoxicity Model , 2013, Renal failure.
[22] A. Marcus,et al. Dysregulation of mTOR activity through LKB1 inactivation , 2013, Chinese journal of cancer.
[23] J. Sage,et al. RB goes mitochondrial. , 2013, Genes & development.
[24] B. Hemmerlein,et al. Macrophage-tumor cell interactions regulate the function of nitric oxide , 2013, Front. Physiol..
[25] A. Carnero,et al. Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia , 2013, PloS one.
[26] H. Mühl,et al. Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury. , 2013, The American journal of pathology.
[27] Sohita Dhillon. Everolimus in Combination with Exemestane: A Review of its Use in the Treatment of Patients with Postmenopausal Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer , 2013, Drugs.
[28] A. Schmid,et al. Selective poisoning of Ctnnb1-mutated hepatoma cells in mouse liver tumors by a single application of acetaminophen , 2013, Archives of Toxicology.
[29] S. Costantini,et al. Evaluation of Selenite Effects on Selenoproteins and Cytokinome in Human Hepatoma Cell Lines , 2013, Molecules.
[30] G. Stephanopoulos,et al. Loss of RBF1 changes glutamine catabolism. , 2013, Genes & development.
[31] T. Roberts,et al. Carcinogen-specific mutational and epigenetic alterations in INK4A, INK4B and p53 tumour-suppressor genes drive induced senescence bypass in normal diploid mammalian cells , 2013, Oncogene.
[32] P. Través,et al. Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game , 2012, Mediators of inflammation.
[33] M. Lingen,et al. The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7. , 2012, Neoplasia.
[34] J. Bagaitkar,et al. Cotinine inhibits the pro-inflammatory response initiated by multiple cell surface Toll-like receptors in monocytic THP cells , 2012, Tobacco induced diseases.
[35] S. Paduano,et al. Effect of Nickel Chloride on Cell Proliferation , 2012, The open dentistry journal.
[36] Taro Hitosugi,et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. , 2012, Cancer cell.
[37] A. González-Angulo,et al. Everolimus in the treatment of hormone receptor-positive breast cancer , 2012, Expert opinion on investigational drugs.
[38] Claudio Franceschi,et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging , 2012, Mechanisms of Ageing and Development.
[39] Chan-Min Liu,et al. Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-κB pathway. , 2012, Biochimica et biophysica acta.
[40] F. Sugawara,et al. Anti-cancer targeting telomerase inhibitors: β-rubromycin and oleic acid. , 2012, Mini reviews in medicinal chemistry.
[41] C. Fan,et al. Akt signaling-associated metabolic effects of dietary gold nanoparticles in Drosophila , 2012, Scientific Reports.
[42] T. Cai,et al. The Role of α-synuclein and Tau Hyperphosphorylation-Mediated Autophagy and Apoptosis in Lead-induced Learning and Memory Injury , 2012, International journal of biological sciences.
[43] T. Fujiwara,et al. The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment , 2012, PloS one.
[44] M. Kuczyk,et al. Second-line systemic therapy for the treatment of metastatic renal cell cancer , 2012, Expert review of anticancer therapy.
[45] H. Yamazaki,et al. Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathway. , 2012, The Journal of toxicological sciences.
[46] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[47] Chih-Hsien Wu,et al. Nickel-induced Epithelial-Mesenchymal Transition by Reactive Oxygen Species Generation and E-cadherin Promoter Hypermethylation* , 2012, The Journal of Biological Chemistry.
[48] Kyung-Chul Choi,et al. Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway. , 2012, International journal of molecular medicine.
[49] P. Nair,et al. Curcumin and resveratrol in combination modulates benzo(a)pyrene-induced genotoxicity during lung carcinogenesis , 2012, Human & experimental toxicology.
[50] C. Barnett. Everolimus: Targeted Therapy on the Horizon for the Treatment of Breast Cancer , 2012, Pharmacotherapy.
[51] U. Testa,et al. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer , 2012, Journal of Hematology & Oncology.
[52] J. Park,et al. Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation , 2012, International journal of nanomedicine.
[53] A. Mollbrink,et al. The effect of sodium selenite on liver growth and thioredoxin reductase expression in regenerative and neoplastic liver cell proliferation. , 2012, Biochemical pharmacology.
[54] Yushui Ma,et al. Effect of lead on apoptosis in cultured rat primary osteoblasts , 2012, Toxicology and industrial health.
[55] U. Moll,et al. Links between mutant p53 and genomic instability , 2012, Journal of cellular biochemistry.
[56] T. von Zglinicki,et al. Mitochondrial dysfunction and cell senescence — skin deep into mammalian aging , 2012, Aging.
[57] Jinhee Choi,et al. Silver nanoparticles down-regulate Nrf2-mediated 8-oxoguanine DNA glycosylase 1 through inactivation of extracellular regulated kinase and protein kinase B in human Chang liver cells. , 2011, Toxicology letters.
[58] C. Plass,et al. Cancer chemoprevention by targeting the epigenome. , 2011, Current drug targets.
[59] A. Bader,et al. Paracetamol treatment increases telomerase activity in rat embryonic liver cells , 2011, Pharmacological reports : PR.
[60] Xianglin Shi,et al. Activation of Akt/GSK3β and Akt/Bcl-2 signaling pathways in nickel-transformed BEAS-2B cells. , 2011, International journal of oncology.
[61] L. Duntas,et al. Resveratrol and its impact on aging and thyroid function , 2011, Journal of endocrinological investigation.
[62] E. Tichy,et al. Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cells , 2011, Experimental biology and medicine.
[63] M. Korc,et al. Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions. , 2011, Gastroenterology.
[64] S. Peregrina,et al. Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation , 2011, Cell cycle.
[65] C. Harley,et al. The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence , 2011, Aging cell.
[66] S. Flora. Arsenic-induced oxidative stress and its reversibility. , 2011, Free radical biology & medicine.
[67] M. Barbacid,et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. , 2011, Cancer cell.
[68] H. Kondoh,et al. MicroRNAs Regulate Key Effector Pathways of Senescence , 2011, Journal of aging research.
[69] A. Carnero,et al. Epigenetic mechanisms in senescence, immortalisation and cancer , 2011, Biological reviews of the Cambridge Philosophical Society.
[70] J. Viña,et al. The dual role of p53: DNA protection and antioxidant , 2011, Free radical research.
[71] A. Wróbel,et al. Effect of bisphenol-A on the expression of selected genes involved in cell cycle and apoptosis in the OVCAR-3 cell line. , 2011, Toxicology letters.
[72] A. Gudkov,et al. Inflammation and p53: A Tale of Two Stresses. , 2011, Genes & cancer.
[73] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[74] Jin Won Hyun,et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. , 2011, Toxicology letters.
[75] C. Harley,et al. A natural product telomerase activator as part of a health maintenance program. , 2011, Rejuvenation research.
[76] J. Campisi. Cellular senescence: putting the paradoxes in perspective. , 2011, Current opinion in genetics & development.
[77] Hongyu Zhou,et al. Role of mTOR signaling in tumor cell motility, invasion and metastasis. , 2011, Current protein & peptide science.
[78] C. Coffill,et al. The role of mutant p53 in human cancer , 2011, The Journal of pathology.
[79] Dong Woo Kim,et al. Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. , 2010, Nitric oxide : biology and chemistry.
[80] Guy C. Brown,et al. Nitric oxide and neuronal death. , 2010, Nitric oxide : biology and chemistry.
[81] C. Lawless,et al. Quantitative assessment of markers for cell senescence , 2010, Experimental Gerontology.
[82] D. Sabatini,et al. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. , 2010, Molecular cell.
[83] M. Chovanec,et al. Selenium: a double-edged sword for defense and offence in cancer , 2010, Archives of Toxicology.
[84] M. Mathieu,et al. DNA Damage Repair and Telomere Length in Normal Breast, Preneoplastic Lesions, and Invasive Cancer , 2010, American journal of clinical oncology.
[85] T. Tollefsbol,et al. Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines , 2010, PloS one.
[86] A. Carnero,et al. Bypassing cellular senescence by genetic screening tools , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[87] A. Gudkov,et al. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway , 2010, Aging.
[88] A. Nikitin,et al. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer. , 2010, International journal of oncology.
[89] D. S. St. Clair,et al. Manganese superoxide dismutase: beyond life and death , 2010, Amino Acids.
[90] M. Antoch,et al. Rapamycin extends maximal lifespan in cancer-prone mice. , 2010, The American journal of pathology.
[91] Tsu-Kung Lin,et al. Nickel(II)-Induced Oxidative Stress, Apoptosis, G2/M Arrest, and Genotoxicity in Normal Rat Kidney Cells , 2010, Journal of toxicology and environmental health. Part A.
[92] J. Clohessy,et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. , 2010, The Journal of clinical investigation.
[93] W. Link,et al. Understanding FOXO, new views on old transcription factors. , 2010, Current cancer drug targets.
[94] O. Renner,et al. Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models , 2010, PloS one.
[95] M. Blagosklonny. Calorie restriction: Decelerating mTOR-driven aging from cells to organisms (including humans) , 2010, Cell cycle.
[96] Jason R. Hickok,et al. Nitric oxide and cancer therapy: the emperor has NO clothes. , 2010, Current pharmaceutical design.
[97] J. Campisi,et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. , 2010, Annual review of pathology.
[98] Ian Indans,et al. Acute toxicity testing of chemicals—Opportunities to avoid redundant testing and use alternative approaches , 2010, Critical reviews in toxicology.
[99] W. Mooi,et al. Oncogene-induced Cellular Senescence , 2010, Advances in anatomic pathology.
[100] M. Blagosklonny. TOR-driven aging: Speeding car without brakes , 2009, Cell cycle.
[101] Laura Lentini,et al. CENPA overexpression promotes genome instability in pRb-depleted human cells , 2009, Molecular Cancer.
[102] L. Morbidelli,et al. Molecular regulation of tumour angiogenesis by nitric oxide. , 2009, European cytokine network.
[103] Varda Rotter,et al. When mutants gain new powers: news from the mutant p53 field , 2009, Nature Reviews Cancer.
[104] S. Eom,et al. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. , 2009, Colloids and surfaces. B, Biointerfaces.
[105] T. Tollefsbol,et al. Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms , 2009, International journal of cancer.
[106] P. Allavena,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[107] K. Srivenugopal,et al. Does aspirin acetylate multiple cellular proteins? (Review). , 2009, Molecular medicine reports.
[108] David R Bickers,et al. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. , 2009, Archives of biochemistry and biophysics.
[109] Hongyang Wang,et al. Effects of Nickel on Cyclin Expression, Cell Cycle Progression and Cell Proliferation in Human Pulmonary Cells , 2009, Cancer Epidemiology Biomarkers & Prevention.
[110] O. Renner,et al. Mouse models to decipher the PI3K signaling network in human cancer. , 2009, Current molecular medicine.
[111] S. Haferkamp,et al. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence , 2009, Aging.
[112] Max Costa,et al. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. , 2009, Metallomics : integrated biometal science.
[113] T. Hupp,et al. The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway , 2009, Aging.
[114] Hong Sun,et al. Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. , 2009, Toxicology and applied pharmacology.
[115] T. Jacob,et al. The effect of cotinine on telomerase activity in human vascular smooth muscle cells. , 2009, The Journal of cardiovascular surgery.
[116] C. Cordon-Cardo,et al. Inactivation of p53 and Pten promotes invasive bladder cancer. , 2009, Genes & development.
[117] C. Mondello,et al. Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex , 2009, Cytogenetic and Genome Research.
[118] H. Kondoh,et al. Senescence induction; a possible cancer therapy , 2009, Molecular Cancer.
[119] J. Leal,et al. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation. , 2008, Cancer research.
[120] Judith Campisi,et al. Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.
[121] C. Harley,et al. Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes1 , 2008, The Journal of Immunology.
[122] M. Blagosklonny,et al. Growth stimulation leads to cellular senescence when the cell cycle is blocked , 2008, Cell cycle.
[123] M. Blagosklonny,et al. Aging: ROS or TOR , 2008, Cell cycle.
[124] Y. Shang,et al. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt‐dependent mechanisms , 2008, British Journal of Pharmacology.
[125] W. Ji,et al. Comparison of global DNA methylation profiles in replicative versus premature senescence. , 2008, Life sciences.
[126] J. Leal,et al. Characterization of the p53 Response to Oncogene-Induced Senescence , 2008, PloS one.
[127] A. Meeker,et al. Id1 delays senescence of primary human melanocytes , 2008, Molecular carcinogenesis.
[128] J. Sage,et al. Cellular mechanisms of tumour suppression by the retinoblastoma gene , 2008, Nature Reviews Cancer.
[129] S. Todo,et al. Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy , 2008, Cell transplantation.
[130] Keshav K. Singh,et al. Arsenic-induced health effects and genetic damage in keratotic individuals: involvement of p53 arginine variant and chromosomal aberrations in arsenic susceptibility. , 2008, Mutation research.
[131] E. Brown,et al. Replicative stress, stem cells and aging , 2008, Mechanisms of Ageing and Development.
[132] F. D. D. Fagagna. Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.
[133] S. Raguz,et al. Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.
[134] S. Jones,et al. Many roads lead to oncogene-induced senescence , 2008, Oncogene.
[135] B. Aggarwal,et al. Resveratrol: A multitargeted agent for age-associated chronic diseases , 2008, Cell cycle.
[136] J. Shay,et al. Immortalization of epithelial progenitor cells mediated by resveratrol , 2008, Oncogene.
[137] A. Brunet,et al. The FoxO code , 2008, Oncogene.
[138] Zhiwei Wang,et al. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. , 2008, Cancer research.
[139] D. Renaud,et al. Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells. , 2008, Biochimica et biophysica acta.
[140] D. Peeper,et al. BRAFE600 in benign and malignant human tumours , 2008, Oncogene.
[141] D. Roy,et al. Allelic loss and mutations in a new ETRG-1 gene are early events in diethylstilbestrol-induced renal carcinogenesis in Syrian hamsters. , 2008, Gene.
[142] Y. Nakagawa,et al. Genotoxic effects of environmental estrogen-like compounds in CHO-K1 cells. , 2008, Mutation research.
[143] M. Hung,et al. All Roads Lead to mTOR: Integrating Inflammation and Tumor Angiogenesis , 2007, Cell cycle.
[144] J. Bartek,et al. DNA damage signalling guards against activated oncogenes and tumour progression , 2007, Oncogene.
[145] S. Gerson,et al. The role of DNA damage repair in aging of adult stem cells , 2007, Nucleic acids research.
[146] M. Chau,et al. Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. , 2007, Carcinogenesis.
[147] E. Greer,et al. FOXO transcription factors in ageing and cancer , 2007, Acta physiologica.
[148] J. Leal,et al. PPP1CA contributes to the senescence program induced by oncogenic Ras. , 2007, Carcinogenesis.
[149] M. Nagarkatti,et al. Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation. , 2007, Cancer research.
[150] Carmen Blanco-Aparicio,et al. PTEN, more than the AKT pathway. , 2007, Carcinogenesis.
[151] Y. Takei,et al. Role of apoptosis in acetaminophen hepatotoxicity , 2007, Journal of gastroenterology and hepatology.
[152] P. Hornsby,et al. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. , 2007, Cancer research.
[153] M. Barbacid,et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.
[154] Carlos Cordon-Cardo,et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas , 2007, Nature.
[155] C. Zhu,et al. Ginkgo Biloba Extract Reduces Endothelial Progenitor-Cell Senescence Through Augmentation of Telomerase Activity , 2007, Journal of cardiovascular pharmacology.
[156] A. Carnero,et al. Cellular Senescence as a Target in Cancer Control , 2007, Journal of aging research.
[157] M. Lipinski,et al. Definition of pRB- and p53-Dependent and -Independent Steps in HIRA/ASF1a-Mediated Formation of Senescence-Associated Heterochromatin Foci , 2007, Molecular and Cellular Biology.
[158] A. Holmgren,et al. The thioredoxin system in cancer. , 2006, Seminars in cancer biology.
[159] H. Tseng,et al. Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma. , 2006, World journal of gastroenterology.
[160] P. Puigserver,et al. Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.
[161] Anke Sparmann,et al. Polycomb silencers control cell fate, development and cancer , 2006, Nature Reviews Cancer.
[162] Aaron Bensimon,et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.
[163] D. Peeper,et al. Oncogene-induced cell senescence--halting on the road to cancer. , 2006, The New England journal of medicine.
[164] G. Peters,et al. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.
[165] G. Zupi,et al. Involvement of RB gene family in tumor angiogenesis , 2006, Oncogene.
[166] D. Green,et al. Dissecting p53-dependent apoptosis , 2006, Cell Death and Differentiation.
[167] M. Serrano,et al. The power and the promise of oncogene-induced senescence markers , 2006, Nature Reviews Cancer.
[168] Jason A. Koutcher,et al. Identification of a tumour suppressor network opposing nuclear Akt function , 2006, Nature.
[169] C. Schmitt,et al. Oncogene-induced senescence: putting the brakes on tumor development. , 2006, Cancer research.
[170] Y. Lu,et al. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway , 2006, Apoptosis.
[171] D. Fruman,et al. FOXO Transcription Factors Cooperate with δEF1 to Activate Growth Suppressive Genes in B Lymphocytes1 , 2006, The Journal of Immunology.
[172] S. Kyo,et al. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. , 2006, Cancer research.
[173] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[174] D. Trono,et al. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes. , 2005, Journal of hepatology.
[175] M. Djamgoz,et al. Nitric oxide and metastatic cell behaviour , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.
[176] Yuan-Ming Yeh,et al. Potent inhibition of human telomerase by helenalin. , 2005, Cancer letters.
[177] H. Schröder,et al. Aspirin reduces endothelial cell senescence. , 2005, Biochemical and biophysical research communications.
[178] Weili Ma,et al. p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest , 2005, Molecular and Cellular Biology.
[179] S. Schwarze,et al. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. , 2005, Neoplasia.
[180] David Beach,et al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus , 2005, Oncogene.
[181] H. Stein,et al. Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.
[182] Jason A. Koutcher,et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.
[183] Goberdhan P Dimri,et al. Mammary epithelial cell transformation: insights from cell culture and mouse models , 2005, Breast Cancer Research.
[184] R. Weinberg,et al. The signals and pathways activating cellular senescence. , 2005, The international journal of biochemistry & cell biology.
[185] J. Cigudosa,et al. Immortalization of primary human prostate epithelial cells by c-Myc. , 2005, Cancer research.
[186] A. Mantovani,et al. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.
[187] Á. Avezum,et al. [Risk factors associated with acute myocardial infarction in the São Paulo metropolitan region: a developed region in a developing country]. , 2005, Arquivos brasileiros de cardiologia.
[188] E. Grimm,et al. NO news is not necessarily good news in cancer. , 2005, Current cancer drug targets.
[189] David Beach,et al. Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.
[190] A. Lin,et al. Molecular signature of oncogenic ras-induced senescence , 2004, Oncogene.
[191] H. Schreiber,et al. Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.
[192] S. Kyo,et al. Bisphenol A from dental polycarbonate crown upregulates the expression of hTERT. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.
[193] K. Chin,et al. In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.
[194] D. Beach,et al. Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation , 2004, Oncogene.
[195] H. Nam,et al. The delayed leaf senescence mutants of Arabidopsis, ore1, ore3, and ore9 are tolerant to oxidative stress. , 2004, Plant & cell physiology.
[196] John M Sedivy,et al. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.
[197] M. Grzmil,et al. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells. , 2004, The Journal of urology.
[198] Z. Radisavljevic. Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells , 2004, Journal of cellular biochemistry.
[199] J. Shay,et al. Hallmarks of senescence in carcinogenesis and cancer therapy , 2004, Oncogene.
[200] A. Carrera,et al. Phosphoinositide 3-kinase and Forkhead, a switch for cell division. , 2004, Biochemical Society transactions.
[201] J. Kleibeuker,et al. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract , 2004, Apoptosis.
[202] S. Lowe,et al. Executing Cell Senescence , 2004, Cell cycle.
[203] E. Blackburn,et al. Telomeres and telomerase. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[204] R. DePinho,et al. Telomeres, stem cells, senescence, and cancer. , 2004, The Journal of clinical investigation.
[205] Timothy B Sackton,et al. The effects of dietary coenzyme Q on Drosophila life span , 2003, Aging cell.
[206] N. Carter,et al. A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.
[207] Xu Wang,et al. Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells. , 2003, World journal of gastroenterology.
[208] Phuong Chung,et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.
[209] Bernhard Brüne,et al. Nitric oxide: NO apoptosis or turning it ON? , 2003, Cell Death and Differentiation.
[210] T. Jacks,et al. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry , 2003, Nature.
[211] S. Lowe,et al. Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.
[212] M. Oren,et al. Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation , 2003, Cell Death and Differentiation.
[213] G. Saretzki,et al. Extracellular Superoxide Dismutase Is a Major Antioxidant in Human Fibroblasts and Slows Telomere Shortening* , 2003, The Journal of Biological Chemistry.
[214] Goberdhan P Dimri,et al. Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1 , 2003, Molecular and Cellular Biology.
[215] E. Harlow,et al. The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.
[216] M. Hosokawa. A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice , 2002, Mechanisms of Ageing and Development.
[217] A. Menssen,et al. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. , 2002, Cancer research.
[218] Karl Münger,et al. Human papillomavirus immortalization and transformation functions. , 2002, Virus research.
[219] P. Jhabvala,et al. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. , 2002, Cancer letters.
[220] J. Shay,et al. Telomerase: a target for cancer therapeutics. , 2002, Cancer cell.
[221] Christian Sell,et al. Role of the Raf/MEK/ERK and the PI3K/Akt(PKB) pathways in fibroblast senescence , 2002, Experimental Gerontology.
[222] L. Elmore,et al. Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction* , 2002, The Journal of Biological Chemistry.
[223] F. McCormick,et al. The RB and p53 pathways in cancer. , 2002, Cancer cell.
[224] S. Lowe,et al. Oncogenic ras and p53 Cooperate To Induce Cellular Senescence , 2002, Molecular and Cellular Biology.
[225] Luigi Perbellini,et al. Lead induced DNA strand breaks in lymphocytes of exposed workers: role of reactive oxygen species and protein kinase C. , 2002, Mutation research.
[226] Tomomi Sato,et al. Developmental effects of perinatal exposure to bisphenol-A and diethylstilbestrol on reproductive organs in female mice. , 2002, Reproductive toxicology.
[227] Moshe Oren,et al. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis , 2002, Oncogene.
[228] Weidong Zhao,et al. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. , 2002, The American journal of pathology.
[229] C. Clarke,et al. Extension of Life-Span in Caenorhabditis elegans by a Diet Lacking Coenzyme Q , 2002, Science.
[230] M. Blasco,et al. Putting the stress on senescence. , 2001, Current opinion in cell biology.
[231] J. Campisi,et al. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[232] C. Mothersill,et al. Heavy metals of relevance to human health induce genomic instability , 2001, The Journal of pathology.
[233] A. Berns,et al. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice , 2001, Nature.
[234] D. Carrasco,et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis , 2001, Nature.
[235] B. Brüne,et al. Transcription factors p53 and HIF-1α as targets of nitric oxide , 2001 .
[236] R. Alani,et al. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[237] Sang-Oh Yoon,et al. Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells* , 2001, The Journal of Biological Chemistry.
[238] K. Kitchin. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. , 2001, Toxicology and applied pharmacology.
[239] S. Lowe,et al. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[240] T. Cotter,et al. Signalling apoptosis: a radical approach , 2001, Redox report : communications in free radical research.
[241] P. Pandolfi,et al. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse , 2001, Nature Genetics.
[242] C. Davis,et al. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. , 2000, The Journal of nutrition.
[243] S. Salama,et al. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[244] I. Naasani. Telomerase inhibitors: forcing the end to put an end. , 2000, Drug news & perspectives.
[245] W. Park,et al. Senescence-like changes induced by hydroxyurea in human diploid fibroblasts , 2000, Experimental Gerontology.
[246] E. Lam,et al. Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1 * , 2000, The Journal of Biological Chemistry.
[247] Pier Paolo Pandolfi,et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.
[248] J. Hong,et al. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NF-kappaB by acetaminophen and salicylates. , 2000, Biochemical and biophysical research communications.
[249] Qin M. Chen,et al. Replicative Senescence and Oxidant‐Induced Premature Senescence: Beyond the Control of Cell Cycle Checkpoints , 2000, Annals of the New York Academy of Sciences.
[250] S. Mikalsen,et al. Morphological transformation and effect on gap junction intercellular communication in Syrian hamster embryo cells as screening tests for carcinogens devoid of mutagenic activity. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.
[251] D. Beach,et al. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization , 2000, Nature Cell Biology.
[252] G. Semenza,et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. , 2000, Genes & development.
[253] S. Kaul,et al. 5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species. , 1999, Journal of biochemistry.
[254] Cheng Jiang,et al. Selenium‐induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake , 1999, Molecular carcinogenesis.
[255] G. Hannon,et al. A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity , 1999, The Journal of experimental medicine.
[256] T. Sasaguri,et al. Tumor Suppressor p53 But Not cGMP Mediates NO-Induced Expression of p21Waf1/Cip1/Sdi1 in Vascular Smooth Muscle Cells , 1999 .
[257] B. Price,et al. Caffeine inhibits the checkpoint kinase ATM , 1999, Current Biology.
[258] M V Chernov,et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.
[259] M. Serrano,et al. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras , 1999, Oncogene.
[260] I. Roninson,et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs , 1999, Oncogene.
[261] E. Kandel,et al. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. , 1999, Cancer research.
[262] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[263] S. Toyokuni,et al. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats , 1999, Oncogene.
[264] M. Newton,et al. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. , 1999, Cancer research.
[265] L. Chin,et al. p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis , 1999, Cell.
[266] J. Sedivy,et al. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. , 1999, Cancer research.
[267] R. DePinho,et al. Telomere-dependent senescence , 1999, Nature biotechnology.
[268] V. Ferrans,et al. Ras Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species* , 1999, The Journal of Biological Chemistry.
[269] R. DePinho,et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.
[270] D. Griffin,et al. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization , 1998, Oncogene.
[271] W. Hahn,et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[272] J. Sham,et al. Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. , 1998, Cancer research.
[273] S. Lowe,et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.
[274] M. Serrano,et al. p19ARF links the tumour suppressor p53 to Ras , 1998, Nature.
[275] J. Blaydes,et al. The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2 , 1998, Oncogene.
[276] G. Hannon,et al. Myc activates telomerase. , 1998, Genes & development.
[277] A. Elia,et al. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons , 1998, Nature Genetics.
[278] T. Jacks,et al. The retinoblastoma gene family: cousins with overlapping interests. , 1998, Trends in genetics : TIG.
[279] B. Dréno,et al. Comparative study of the in vitro inflammatory activity of three nickel salts on keratinocytes. , 1998, Acta dermato-venereologica.
[280] G. Adami,et al. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts , 1998, Oncogene.
[281] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[282] Wenyi Wei,et al. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. , 1997, Science.
[283] G. Peters,et al. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status , 1997, Oncogene.
[284] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[285] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[286] J. Blaydes,et al. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. , 1996, Oncogene.
[287] David Wynford-Thomas,et al. REVIEW ARTICLE. p53: GUARDIAN OF CELLULAR SENESCENCE , 1996 .
[288] O. Pereira-smith,et al. Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression , 1996, Science.
[289] U. Stenius,et al. Low expression of the WAF1/CIP1 gene product, p21, in enzyme-altered foci induced in rat liver by diethylnitrosamine or phenobarbital. , 1996, Cancer letters.
[290] T. Osawa,et al. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme. , 1996, Archives of biochemistry and biophysics.
[291] E. Blackburn,et al. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines , 1996, Molecular and cellular biology.
[292] Atsushi Namiki,et al. Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.
[293] J. Shay,et al. Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? , 1995, Trends in cell biology.
[294] G. Mills,et al. Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. , 1995, Cancer research.
[295] A. Cuthbert,et al. Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. , 1995, Carcinogenesis.
[296] G. Wahl,et al. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.
[297] A. Carnero,et al. Regulation of ras proteins and their involvement in signal-transduction pathways (review). , 1994, Oncology reports.
[298] R. S. Sohal,et al. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. , 1994, Science.
[299] R. Metcalf,et al. p53 mutations in human immortalized epithelial cell lines. , 1993, Carcinogenesis.
[300] R. Reddel,et al. Assignment of SV40-immortalized cells to more than one complementation group for immortalization. , 1993, Experimental cell research.
[301] C. Lafarge‐Frayssinet,et al. Over expression of proto-oncogenes: ki-ras, fos and myc in rat liver cells treated in vitro by two liver tumor promoters: phenobarbital and biliverdin. , 1989, Cancer letters.
[302] M. Stampfer,et al. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[303] R. Newbold,et al. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene , 1983, Nature.
[304] R. Newbold,et al. Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens , 1982, Nature.
[305] R. Newbold,et al. Mutagenicity of carcinogenic methylating agents is associated with a specific DNA modification , 1980, Nature.
[306] A M Olovnikov,et al. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.
[307] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.
[308] D. Harman. Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.
[309] R. Virchow. Reizung und Reizbarkeit , 1858, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[310] M. Narita,et al. Cell senescence as both a dynamic and a static phenotype. , 2013, Methods in molecular biology.
[311] Clara Correia-Melo,et al. Robust multiparametric assessment of cellular senescence. , 2013, Methods in molecular biology.
[312] A. Carnero,et al. Markers of cellular senescence. , 2013, Methods in molecular biology.
[313] A. Carnero. The PKB/AKT pathway in cancer. , 2010, Current pharmaceutical design.
[314] R. DePinho,et al. Telomeres and telomerase in cancer. , 2010, Carcinogenesis.
[315] C. Schmitt. Cellular senescence and cancer treatment. , 2007, Biochimica et biophysica acta.
[316] D. Bernard,et al. Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. , 2007, Histology and histopathology.
[317] Seung-Rock Lee,et al. Down-regulation of a forkhead transcription factor, FOXO3a, accelerates cellular senescence in human dermal fibroblasts. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[318] Goberdhan P Dimri,et al. Mechanisms of cellular senescence in human and mouse cells , 2004, Biogerontology.
[319] P. Tchounwou,et al. Lead-induced cytotoxicity and transcriptional activation of stress genes in human liver carcinoma (HepG2) cells , 2004, Molecular and Cellular Biochemistry.
[320] M. Altinoz,et al. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. , 2004, Neoplasma.
[321] Xianglin Shi,et al. Oxidative mechanism of arsenic toxicity and carcinogenesis , 2004, Molecular and Cellular Biochemistry.
[322] M. Serrano. Proliferation: the cell cycle. , 2003, Advances in experimental medicine and biology.
[323] M. Malumbres,et al. Cell cycle deregulation: a common motif in cancer. , 2003, Progress in cell cycle research.
[324] M. Kang,et al. Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes. , 2001, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[325] C. Harris,et al. Cancer-prone oxyradical overload disease. , 1999, IARC scientific publications.
[326] G. Hannon,et al. The INK4 family of CDK inhibitors. , 1998, Current topics in microbiology and immunology.
[327] A. Atkinson,et al. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. , 1997, Journal of toxicology and environmental health.
[328] S. Toyokuni,et al. Iron-induced carcinogenesis: the role of redox regulation. , 1996, Free radical biology & medicine.
[329] V. Krutovskikh,et al. Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication. , 1996, Nutrition and cancer.
[330] A. Okamoto,et al. p16INK4 mutations and altered expression in human tumors and cell lines. , 1994, Cold Spring Harbor symposia on quantitative biology.
[331] J. Huff,et al. Reserpine-induced cell transformation without detectable genetic effects in Syrian hamster embryo cells in culture. , 1994, Carcinogenesis.
[332] J. Barrett,et al. Cellular senescence and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.
[333] R. Metcalf,et al. Altered p53 gene structure and expression in human epithelial cells after exposure to nickel. , 1992, Cancer research.
[334] A. Dulhunty. The voltage-activation of contraction in skeletal muscle. , 1992, Progress in biophysics and molecular biology.